Celiac Disease Clinical Trials 2024

Celiac Disease Clinical Trials 2024

Celiac Disease research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in celiac disease clinical trials today.

Celiac Disease Clinical Trials

Here are the 6 most popular medical studies for celiac disease

Popular filter options for celiac disease trials

Celiac Disease Clinical Trials With No Placebo

View 20 celiac disease medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to celiac disease

What are the top hospitals conducting celiac disease research?

When it comes to advancing our understanding and treatment options for celiac disease, several hospitals across the United States are leading the way. One such institution is the Mayo Clinic in Rochester, which currently has four active clinical trials focused on this condition. With a total of 11 trials conducted over time since their first recorded trial in 1995, the Mayo Clinic is dedicated to finding innovative solutions for those affected by celiac disease. In Boston, both Massachusetts General Hospital and Beth Israel Deaconess Medical Center are making significant contributions as well. They each have three ongoing clinical trials related to celiac disease and have been conducting research since recording their first trial in 2009.

Further expanding the reach of these pioneering medical facilities, we look westward to Iowa City where researchers at the University of Iowa are actively involved in two clinical trials centered on celiac disease. Although they may be relatively new players in this field with only two recorded trials starting from 2018 onwards so far, their commitment is evident.

Notably smaller-scale yet equally important is Diablo Clinical Research located in Walnut Creek. This regional center focuses on cutting-edge investigations into various health conditions including celiac disease. Currently conducting two active clinical trials and having completed three previous studies since initiating its first trial also back in 2018; Diablo Clinical Research demonstrates that progress can occur at any scale.

These hospitals' dedication to studying celiac disease through rigorous clinical research not only provides hope for better diagnosis methods but also leads us closer towards effective treatments or even potential future cure for this autoimmune disorder affecting millions worldwide.

Which are the best cities for celiac disease clinical trials?

When it comes to celiac disease clinical trials, several cities are at the forefront of research. In Boston, Massachusetts, there are currently 10 active trials investigating treatments such as TAK-062, Gluten Powder, and Gluten Challenge. Rochester, Minnesota follows closely with 8 ongoing studies focused on therapies like TAK-101 and Cohort 2 in Part A. New york City also plays a significant role with 6 active trials exploring options like TAK-062 and PRV-015. These three cities offer individuals with celiac disease access to cutting-edge clinical trials that may lead to advancements in treatment options and improved quality of life.

Which are the top treatments for celiac disease being explored in clinical trials?

Exciting developments are underway in the realm of celiac disease treatment, with several innovative approaches being explored in recent clinical trials. A standout contender is Cohort 2 in Part A, a cutting-edge trial that aims to offer new possibilities for patients. Equally promising are DONQ52 and TAK-062, both undergoing active trials and showing great potential as future treatments. Additionally, gluten powder and Food for Thought have also emerged as contenders, demonstrating their efficacy through ongoing studies. These advancements hold promise for individuals living with celiac disease and bring hope for improved quality of life in the near future.

What are the most recent clinical trials for celiac disease?

Exciting developments are underway in the realm of celiac disease research, with recent clinical trials offering potential breakthroughs for patients. One such trial focuses on Ritlecitinib, a medication currently in Phase 2 of testing specifically designed to address celiac disease symptoms. Another promising study involves Cohort 2 in Part A, which combines Phase 1 and Phase 2 assessments to evaluate new treatment options. Additionally, DONQ52 and TAK-062 have shown promise as potential therapies through their respective Phase 1 and Phase 2 trials. Lastly, TAK-101 has also displayed encouraging results as it progresses through its own Phase 2 testing phase. These ongoing investigations provide hope for improved management and overall well-being for individuals living with celiac disease.

What celiac disease clinical trials were recently completed?

A recent clinical trial for celiac disease investigated the potential benefits of PTG-100 and was completed in February 2021. Led by Nielsen Fernandez-Becker, this study aimed to uncover new treatments and interventions for individuals living with celiac disease. The completion of this trial signifies an important step forward in understanding and addressing the challenges faced by those affected by this autoimmune disorder.